PopularWeight ManagementGLP-1 Receptor Agonist
or 3 × 43,00 € interest-free
VON FORSCHERN VERTRAUT
Extensively Clinically Studied
STEP, SELECT, and SUSTAIN trials — the most studied GLP-1 agonist in history
>99% HPLC Purity
Every batch independently tested with full Certificate of Analysis included
Once-Weekly Dosing
~168-hour half-life enables convenient weekly administration in research protocols
Research-Accessible Pricing
High-quality research material at a fraction of branded pharmaceutical pricing
A GLP-1 receptor agonist extensively studied in metabolic and weight management research. Clinical trials (STEP program) have demonstrated significant effects on body weight reduction and glycemic control.
DOSIERUNG WÄHLEN
STEP, SELECT, and SUSTAIN trials — the most studied GLP-1 agonist in history
Every batch independently tested with full Certificate of Analysis included
~168-hour half-life enables convenient weekly administration in research protocols
High-quality research material at a fraction of branded pharmaceutical pricing
Choose your preferred bacteriostatic water volume for metabolic research. The lyophilized format allows custom concentration preparation.
Calculate exact doses for your incretin research protocol. Titration studies require precise concentration control that vials enable.
Lyophilized form stable for 24+ months when stored properly at 2-8°C. Reconstituted solution stable for 30 days refrigerated.
Research-grade semaglutide at a fraction of pharmaceutical branded product pricing for laboratory use.
Allow vial to reach room temperature before reconstitution
Add bacteriostatic water slowly along the vial wall
Gently swirl until fully dissolved — do not shake
Draw desired dose using an insulin syringe
Inject subcutaneously in the abdomen, thigh, or upper arm
Store reconstituted vial refrigerated at 2-8°C
Verwenden Sie bei jeder Anwendung eine neue sterile Nadel. Entsorgen Sie gebrauchte Nadeln in einem geeigneten Abwurfbehälter. Lagern Sie das Vial gekühlt bei 2-8°C.
Stack discount applied
Semaglutide
129,00 €
This product
Tirzepatide
139,00 €
AOD-9604
65,00 €
Paketpreis — sparen Sie 33,30 € mit dieser Kombination
GLP-1 Receptor Agonist (long-acting acylated analogue)
C187H291N45O59
4,113.58 g/mol
Approximately 1 week (168 hours)
Semaglutide is an acylated GLP-1 analogue with 94% homology to native GLP-1. It binds to the GLP-1 receptor, stimulating insulin secretion, suppressing glucagon, slowing gastric emptying, and reducing appetite through hypothalamic signalling. The C-18 fatty acid chain enables albumin binding for extended duration.
STEP 1 demonstrated 14.9% mean body weight reduction vs 2.4% with placebo over 68 weeks in adults with obesity.
20% reduction in major adverse cardiovascular events (MACE) in people with overweight/obesity and established cardiovascular disease.
Comprehensive trial program demonstrating superior glycemic control and weight reduction versus comparators across multiple patient populations.
“Access to high-purity semaglutide for our incretin research is invaluable. Peptides Pharma's quality matches what we need for publishable data.”
Dr. J. Holst
Incretin Biology Lab, Copenhagen
“Our internal HPLC confirmed >99.3% purity. The lyophilized format is perfect for our dose-titration metabolic studies.”
Dr. A. Ferrannini
Metabolic Research, Pisa
“Received with cold-chain packaging within 48 hours. Reconstituted cleanly. Our weight management research program relies on this supplier.”
Dr. W. Cefalu
Obesity Research, New Orleans
“Finally a European source for properly formulated research-grade semaglutide in lyophilized vials. Purity verified via HPLC at 98.7%, and delivery to the Netherlands was just four days. Excellent COA documentation.”
Dr. Sophie K.
Amsterdam, Netherlands
“The GLP-1 agonist formulation is spot-on. We've run three independent assays and every result aligns with the COA. Would appreciate more vial size options for different research protocols, but the current 5mg offering is excellent quality.”
Andrew B.
Cardiff, UK
“Quality is excellent and the lyophilized powder reconstitutes cleanly. Would love to see additional vial sizes in the future, but the current offering serves our metabolic research needs well.”
Laura G.
Newcastle, UK
“We've ordered multiple batches for our metabolic research programme. Every vial has been consistent — proper lyophilization, clean reconstitution, and purity matching the COA. Peptides Pharma is our go-to supplier.”
Dr. R. Novak
Prague, Czech Republic
Semaglutide is a pure GLP-1 receptor agonist, while tirzepatide is a dual GIP/GLP-1 agonist. Head-to-head trials (SURPASS-2) showed tirzepatide achieved greater weight loss, though both are highly effective. The choice depends on the specific research question.
COA bei jeder Bestellung enthalten. Chargenspezifische Berichte auf Anfrage erhältlich.
See how Peptides Pharma pre-mixed research vials compare to traditional vials and other suppliers.
| Feature | Peptides Pharma Pens | Traditional Vials | Other Suppliers |
|---|---|---|---|
| Format | Lyophilized vial | Lyophilised powder | Mixed |
| Purity | >99% verified | Variable (70-95%) | Claims vary |
| Dosing accuracy | <2% error | ~15% error | N/A |
| Reconstitution needed | No | Yes | Sometimes |
| Contamination risk | Sealed system | Multi-use vial | Varies |
| COA included | Every order | Rarely | Sometimes |
| GMP certified | Yes | Rarely | Some |
| EU customs-free | Yes | Often no | Varies |
Dieses Produkt ist ausschließlich für Labor- und Forschungszwecke bestimmt. Nicht zum menschlichen Verzehr.
Premium-Fläschchen-System mit vollständig einstellbarer Dosierung. GMP-hergestellt, >99% Reinheit garantiert.
Legal under MHRA rules. BPC-157, tirzepatide & NAD+ vials with worldwide delivery from £99. >99% purity, GMP certified, COA included.
ARTICLEPens cut dosing error from 15% to under 2%. We compare accuracy, contamination risk, cost, and convenience. See why researchers are switching in 2026.
ARTICLEOver 100 published studies back BPC-157 for tissue repair, gut healing, and neuroprotection. Mechanisms, dosing protocols, and where to buy in the UK.
COMPARISONCompare semaglutide and tirzepatide for metabolic research. Single vs dual receptor, efficacy data, side effects, and dosing. Buy research-grade peptide vials.
COMPARISONCompare semaglutide and AOD-9604 for weight management research. GLP-1 signalling vs lipolytic peptide mechanisms. Buy >99% purity research-grade peptides.
ENCYCLOPEDIAGLP-1 Receptor Agonist (Incretin Mimetic). Molecular weight: 4113.58 Da. Explore mechanism of action, key studies, and research applications.
BUNDLEDual-incretin approach for comprehensive metabolic research
PROTOCOLResearch protocol for Semaglutide and Tirzepatide lyophilized vials investigating GLP-1 and dual GIP/GLP-1 receptor agonism. Explore metabolic mechanisms, dose titration, and landmark clinical trial data.
FAQSemaglutide research FAQ. Learn about GLP-1 receptor agonist mechanisms, metabolic research, purity, storage, reconstitution, and research applications.
CATEGORYResearch-grade recovery research vials. BPC-157 and TB-500 for tissue repair, wound healing, and inflammation research. >99% purity, UK delivery.
CATEGORYResearch-grade weight loss research vials. Tirzepatide dual GIP/GLP-1 agonist for metabolic research. Lyophilized vials, >99% purity, worldwide delivery.
Single and Dual Incretin Metabolic Optimization
Semaglutide research FAQ. Learn about GLP-1 receptor agonist mechanisms, metabolic research, purity, storage, reconstitution, and research applications.
